New Version of the LifeScience-Portal(TM) Offers Most Direct Route to Analyzing the Lifescience Market

Share Article

The Lifescience-Portal(TM) offers the most direct route to analyzing the lifescience market and its constituents. The result of two years development and close collaboration with clients worldwide, the LifeScience-Portal(TM) offers in-depth drugs characterization, new customized-modelling of key market indicators, streamlined market analysis (global and regional), and a user-friendly interface for intuitive navigation. With over 13000 current drugs and 5000 active companies worldwide, there is no better solution you can give to your company than the Lifescience-Portal(TM). Thanks to thousands of chemical structures, the platform is also helping manufacturing and research organizations expanding their customer base.

With this level of integration and richness of information, our customers now have a global solution to support them in building strategies or taking decisions

LifeScience-Consulting SA announced today the new release of the LifeScience-Portal(TM) -- a world class bio-financial solution. The culmination of two years of development work , the LifeScience-Portal now offers the most direct route to analyzing the lifescience market. With the input and support of clients worldwide, the enhanced LifeScience-Portal(TM) now offers customized-modeling of key market indicators, streamlined market analysis, in-depth drugs characterization and an exciting graphical interface for intuitive navigation.

LifeScience-Portal(TM) 4.0 brings three major enhancements:
A Decisional Cockpit proposing indicators to consolidate daily available global information and to sound out and analyze the market. This unique capability is now accessible by retrieving intelligence from the Lifescience-Portal's database composed of 13'000 investigational and marketed drugs and over 5'000 active worldwide-based companies.
A database of drug revenues to facilitate the analysis of regional and global markets, major players and markets' penetration.
Chemical Structures to enrich drug knowledge, support business intelligence and help manufacturing and research organizations expanding their client portfolios.

The Lifescience-Portal(TM) 4.0 offers unique services through a tighter and more agile integration of financial and scientific aspects. By using it our clients are relying on accessible, faster and daily updated reports, in contrast to paper format reports.

"With this level of integration and richness of information, our customers now have a global solution to support them in building strategies or taking decisions", said Thomas Wacinski, CTO of the company. "There are many database systems on the market but most of them focus on a single topic at a time. We believe the Lifescience-Portal(TM) version 4.0 brings synergy between financial and scientific information flows. This represents a major milestone in database development for pharma and biotech intelligence. We believe there is no better solution you can give your company than the Lifescience-Portal(TM)."

More information about the LifeScience-Portal(TM), including trial and subscription information, is available on the Web site http://www.LIFESCIENCE-PORTAL.com or by calling LifeScience-Consulting Customer Service at +41 22 534 94 09.

About LifeScience-Consulting SA
LifeScience-Consulting, SA (http://www.lifescience-consulting.com) is a company focused on the integration of financial and scientific data to provide sophisticated computer models and cutting edge industry knowledge. The Company markets the Lifescience-Portal™ (http://www.lifescience-portal.com), a fully integrated information infrastructure platform improving the complex valuation of pharma/biotech companies and projects. Additionally, the Lifescience-Reports™ are shaped to specifically match customer demands for market analysis, due diligence and projects' valuations.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Carmelo Bisognano
Visit website